EcoDrugPlus

Aromatase-Like

Ensembl ID : ENSXMAG00000002192
Gene Symbol: LOC102231498
3 Cross references
249 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSXMAG00000017442
Gene Symbol: LOC102230348
3 Cross references
190 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSXMAG00000006069
Gene Symbol: AURKA
3 Cross references
232 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSXMAG00000016292
Gene Symbol: LOC102233914
3 Cross references
205 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSXMAG00000019510
Gene Symbol: LOC102226973
3 Cross references
195 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSXMAG00000028966
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSXMAG00000028867
Gene Symbol: BDKRB2
3 Cross references
245 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSXMAG00000012206
Gene Symbol: BDKRB2
1 Cross references
242 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSXMAG00000009979
Gene Symbol: BDKRB2
4 Cross references
161 Possible Orthologues:

Breakpoint Cluster Region Protein-Like

Ensembl ID : ENSXMAG00000004350
Gene Symbol: LOC102222870
3 Cross references
196 Possible Orthologues:

Bromodomain-Containing Protein Ddb_g0280777-Like

Ensembl ID : ENSXMAG00000008034
Gene Symbol: LOC102235349
2 Cross references
190 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSXMAG00000023563
Gene Symbol: BCHE
3 Cross references
130 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).